Literature DB >> 11230862

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome.

M J Roman1, J E Salmon, R Sobel, M D Lockshin, L Sammaritano, J E Schwartz, R B Devereux.   

Abstract

The prevalence of preclinical cardiovascular disease was determined in women with systemic lupus erythematosus (SLE) and control subjects matched for traditional risk factors. Compared with control subjects, patients with SLE had a higher prevalence of carotid atherosclerosis (41% vs 9%, p < 0.005) and left ventricular hypertrophy (32% vs 5%, p < 0.005), supporting the possibility that chronic inflammation predisposes to premature cardiovascular disease in SLE.

Entities:  

Mesh:

Year:  2001        PMID: 11230862     DOI: 10.1016/s0002-9149(00)01453-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Rituximab in childhood lupus myocarditis.

Authors:  Pooja Aggarwal; Surjit Singh; Deepti Suri; Amit Rawat; Nidhi Narula; Rohit ManojKumar
Journal:  Rheumatol Int       Date:  2011-04-06       Impact factor: 2.631

Review 3.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

4.  The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology.

Authors:  Przemyslaw Kotyla
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

5.  Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.

Authors:  Abdulla Watad; Arsalan Abu Much; Danielle Bracco; Naim Mahroum; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

6.  A pravastatin dose-escalation study in systemic lupus erythematosus.

Authors:  Karen H Costenbader; Matthew H Liang; Lori B Chibnik; Juliet Aizer; Hannah Kwon; Victoria Gall; Elizabeth W Karlson
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

7.  B cell depletion reduces the development of atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Olivier Herbin; Jean-David Bouaziz; Christoph J Binder; Catherine Uyttenhove; Ludivine Laurans; Soraya Taleb; Emily Van Vré; Bruno Esposito; José Vilar; Jérôme Sirvent; Jacques Van Snick; Alain Tedgui; Thomas F Tedder; Ziad Mallat
Journal:  J Exp Med       Date:  2010-07-05       Impact factor: 14.307

Review 8.  Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis.

Authors:  Junzhe Chen; Ying Tang; Mingsheng Zhu; Anping Xu
Journal:  Clin Rheumatol       Date:  2016-08-09       Impact factor: 2.980

9.  Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome.

Authors:  G Medina; D Casaos; L J Jara; O Vera-Lastra; M Fuentes; L Barile; M Salas
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

10.  Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.

Authors:  Carlos Borelli Zeller; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.